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The E-domain of cyclodextrin glycosyltransferase
(CGTase) (EC 2.4.1.19) from Bacillus circulans strain 251
is a putative raw starch binding domain. Analysis of the
maltose-dependent CGTase crystal structure revealed
that each enzyme molecule contained three maltose
molecules, situated at contact points between protein
molecules. Two of these maltoses were bound to specific
sites in the E-domain, the third maltose was bound at
the C-domain.
To delineate the roles in raw starch binding and cy-
clization reaction kinetics of the two maltose binding
sites in the E-domain, we replaced Trp-616 and Trp-662
of maltose binding site 1 and Tyr-633 of maltose binding
site 2 by alanines using site-directed mutagenesis. Puri-
fied mutant CGTases were characterized with respect to
raw starch binding and cyclization reaction kinetics on
both soluble and raw starch. The results show that malt-
ose binding site 1 is most important for raw starch bind-
ing, whereas maltose binding site 2 is involved in guid-
ing linear starch chains into the active site.
b-Cyclodextrin causes product inhibition by interfering
with catalysis in the active site and the function of malt-
ose binding site 2 in the E-domain.
CGTase mutants in the E-domain maltose binding site
1 could no longer be crystallized as maltose-dependent
monomers. Instead, the W616A mutant CGTase protein
was successfully crystallized as a carbohydrate-inde-
pendent dimer; its structure has been refined to 2.2 Å
resolution. The three-dimensional structure shows that,
within the error limits, neither the absence of carbohy-
drates nor the W616A mutation caused significant fur-
ther conformational changes. The modified starch bind-
ing and cyclization kinetic properties observed with the
mutant CGTase proteins thus can be directly related to
the amino acid replacements.
Cyclodextrin glycosyltransferase (CGTase, EC 2.4.1.19) con-
verts raw starch into cyclodextrins, which are cyclic oligomers
of a(134) linked glucose residues (1, 2). Cyclodextrins can form
inclusion complexes with small hydrophobic molecules (3) and
are increasingly used in industrial and research applications
(4). The cgt gene of Bacillus circulans strain 251 has been
cloned and sequenced, and the crystal structure of the CGTase
protein has been determined at 2.0 Å resolution (1, 5). The
protein consists of a single polypeptide chain of 686 amino acid
residues; as in other known CGTase structures (6–8), five
domains (A–E) can be recognized. The three N-terminal do-
mains (A–C) have structural similarity with the three a-amy-
lase domains. Domain E contains a raw starch binding motif (5,
9, 10) (see Fig. 1).
In glucoamylases, several Trp residues (Trp-590, Trp-615) in
the domain containing this motif were shown to be essential for
degradation of raw starch (11–13). This domain also has a high
affinity for b-cyclodextrin (14, 15), the binding of which inhibits
starch hydrolysis (16). Also in CGTases, a starch binding site
separate from the active site is present (17), and fusion of the
E-domain of the Bacillus macerans CGTase to b-galactosidase
demonstrated that it can function as a starch binding domain
(18). CGTase is sensitive to product inhibition by cyclodextrin,
which severely limits yields in industrial production processes
(19). Recently, we showed that cyclodextrins bind at the CGT-
ase E-domain (20). This suggested that cyclodextrins may in-
terfere with starch binding.
Here we report a detailed analysis of raw starch binding and
cyclization reaction kinetics of wild-type and mutant CGTase
enzymes with a modified E-domain. Evidence is presented that
the E-domain functions in binding of raw starch and guiding of
linear starch chains into the active site.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Plasmids—Escherichia coliMC1061 (MhsdR
mcrB araD139 D(araABC-leu)7679 DlacX74 galU galK rpsL thi) (21)
was used for recombinant DNA manipulations and site-directed mu-
tagenesis. E. coli DH5a (F9/endA1 hsdR17 supE44 thi1 recA1 gyrA
(Nalr) relA1 (lacZYA-argF) U196 (o80dlacD(lacZ)M15) (22) was used
for the production of monomeric supercoiled plasmid DNA for se-
quencing. CGTase (mutant) proteins were produced with the a-amy-
lase and protease negative Bacillus subtilis strain DB104A (amy
nprR2 nprE18 aprA3) (23). Plasmid pKM1 (Apr Kmr ColE1) (24) was
digested with HincII. The fragment containing the kanamycin resist-
ance marker was ligated with the largest fragment from plasmid
pDP66S (25) containing the B. circulans strain 251 cgt gene digested
with HindIII and XbaI (made blunt with Klenow polymerase). The
resulting CGTase protein expression shuttle vector pDP66K, with the
cgt gene under control of the erythromycin-inducible p32 promoter
(26), was transformed to E. coli MC1061 under selection for erythro-
mycin and kanamycin resistance (see Fig. 2). This plasmid was con-
siderably more stable than plasmid pDP66S, both in E. coli and in B.
subtilis. DNA manipulations and calcium chloride transformation of
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E. coli strains were as described (27). Transformation of B. subtilis
was performed according to Bron (28).
Site-directed Mutagenesis—Mutations were introduced with a PCR1
method using VENT-DNA polymerase (New England Biolabs Inc., Bev-
erly, MA). The first PCR reaction was carried out with a mutagenesis
primer for the coding strand plus a primer 910-1050 bp downstream on
the template strand. The 910-1050-bp reaction product was subse-
quently used as primer in a second PCR reaction together with a primer
760–900 bp upstream on the coding strand. The product of the last
reaction (1800 bp) was cut with BglI and HindIII and exchanged with
the corresponding fragment (600 bp) from the vector pDP66K. The
resulting (mutant) plasmid was transformed to E. coli MC1061 cells.
The following oligonucleotides were used to produce the mutations:
Y633A, 59-G GTC GTT TAC CAG GCG CCG AAC TGG-39; W616A,
59-GC GAG CTC GGG AAC GCG GAC CCG-39; W662A, 59-CC GTC
ACC GCG GAA GGC GGC-39. Successful mutagenesis resulted in the
appearance of the underlined restriction sites, allowing rapid screening
of potential mutants. For Y633A, this restriction site was NarI, for
W616A, it was SacI, and for W662A, it was SacII. A mutation frequency
close to 70% was observed; all mutations were confirmed by restriction
analysis and DNA sequencing.
DNA Sequencing—Plasmid pDP66K carrying the correct restriction
site was transformed to E. coli DH5a cells. DNA sequence determina-
tion was performed on supercoiled plasmid DNA using the dideoxy
chain termination method (29) and the T7 sequencing kit from Phar-
macia Biotech Inc., Sweden.
Growth Conditions and Purification of CGTase Proteins—Plasmid
carrying bacterial strains were grown on LB agar in the presence of the
antibiotics erythromycin and kanamycin, at concentrations of 100 and
5 mg/ml for E. coli and B. subtilis, respectively (27). B. subtilis strain
DB104A with plasmid pDP66K, carrying wild-type or mutant cgt genes,
was grown in a 5-liter flask, containing 1 liter of medium with 2%
trypton, 0.5% yeast extract, 1% sodium chloride, and 1% casamino
acids, pH 7.0, with 10 mg/ml erythromycin and 5 mg/ml kanamycin, to a
final optical density at 600 nm of 4.5 (for approximately 36 h). Under
these conditions, high extracellular CGTase levels were obtained repro-
ducibly, allowing purification to homogeneity of up to 25 mg of CGTase
protein/liter. The culture was centrifuged at 4 °C for 30 min at 10,000 3
g. The (mutant) CGTases in the culture supernatants were further
purified to homogeneity by affinity chromatography, using a 30-ml
a-cyclodextrin-Sepharose-6FF column (Pharmacia, Sweden) (30) with a
maximal capacity of 3.5 mg protein/ml. After washing with 10 mM
sodium acetate buffer, pH 5.5, bound CGTase was eluted with the same
buffer containing 10 mg/ml a-cyclodextrin.
Enzyme Assays—b-Cyclodextrin forming activity was determined by
incubating appropriately diluted enzyme (0.1–0.2 units of activity) for
2–4 min at 50 °C. A 5% solution of partially hydrolyzed potato starch,
with an average degree of polymerization of 50 (Paselli SA2; AVEBE,
Foxhol, The Netherlands), was used as a substrate. At regular time
intervals, samples were taken, and the amount of b-cyclodextrin formed
was determined based on its ability to form a stable colorless inclusion
complex with phenolphthalein (31). One unit of activity is defined as the
amount of enzyme able to produce 1 mmol of b-cyclodextrin/min.
Raw Starch Binding Properties—Raw starch binding properties were
studied by incubating pure (mutant) CGTase (6 mg/ml final concentra-
tion) with increasing amounts (0–10%) of granular potato starch
(AVEBE) at 4 °C for 1 h in the presence and absence of 0.1 mM of
b-cyclodextrin (equilibrium was reached within 10 min). CGTase pro-
tein bound to the starch granules was spun down at 4 °C for 1 min at
10,000 3 g, and the remaining cyclization activity in the supernatant
was measured as described above.
Kinetic studies were performed by measuring b-cyclodextrin forming
activity of (mutant) CGTase enzymes (final concentration 0.6 mg/ml,
equivalent to 0.15–0.18 units) at Paselli SA2 concentrations ranging
from 0–5%, in the presence or absence of 1 or 2 mM of b-cyclodextrin.
Alternatively, kinetic studies were performed by incubating CGTase
enzymes (final concentration 6 mg/ml) for 10 min with raw starch
concentrations ranging from 0–50%; b-cyclodextrin formation was de-
termined as above. All experiments were carried out at least in tripli-
cate. Plots of the data obtained (see Figs. 4–6) were better described
with the Hill equation than the Michaelis-Menten equation, indicating
that some form of cooperativity is involved both in the cyclization
reaction and raw starch binding kinetics. To determine the degree of
cooperativity, the data from these kinetic and binding studies were
fitted with an equation equivalent to the Hill equation (Equation 1)
(32), using the Sigma Plot program (Jandel Scientific). Plotting x versus





In this equation, [S] is the substrate concentration; K50 is equivalent to
the dissociation constant; h is the Hill constant, indicating the degree of
cooperativity involved; x is for the binding studies where b is the fraction
of protein bound to the raw starch, and for the kinetic studies where v is
the velocity of the reaction; Xmax is for the binding studies where Bmax is
the maximal fraction of protein bound to the raw starch, and for the
kinetic studies where Vmax is the maximal velocity of the reaction.
Equation 1 can be rewritten as follows.
logS xXmax 2 xD5 h z log@S# 2 h z logK50 (Eq. 2)1 The abbreviations used are: PCR, polymerase chain reaction; bp,base pairs; MBS, maltose binding sites.
FIG. 1. Alignment of the raw starch binding domains in B.
strain 251 CGTase and Aspergillus niger glucoamylase (GAase)
and the consensus raw starch binding motif (5, 9, 10). Residues
making hydrophobic interactions with a maltose molecule bound in
MBS1 (Trp-616, Tr-662) or MBS2 (Tyr-633) of B. circulans CGTase are
shown in a box (M); those making hydrogen bonds with a maltose
molecule bound in MBS1 or MBS2 are indicated by number 1 and 2,
respectively (5). :, identical residues; ., similar residues.
TABLE I
Data collection statistics and quality of the final model
for the W616A mutant of CGTase
Rmerge is defined as Rmerge 5 (SSIj(hkl) 2 ^I(hkl)&)/(SS^I(hkl)&), and
the crystallographic R-factor is defined as R 5 SFobs 2 Fcalc/







Resolution range (Å) 45.1–2.2
Total number of observations 133691
Number of discarded observations 717
Number of unique reflections 50563
Rmerge 0.083
Completeness of data (%) 71.3
Completeness (%) of last 51.5
Resolution shell (Å) (2.24–2.20)
Number of protein atoms 2 3 5255
Number of calcium atoms 2 3 2
Number of solvent sitesa 119/144
Average B factor (Å2)a 20.0/18.1
Final R factor/R-free (%) 19.3/25.0
Rms deviations from ideality for
Bond lengths (Å) 0.005
Cell dimensions (P21):
Bond angles (deg) 0.72
Torsion angles (deg) 20.1
Trigonal planes (Å) 0.007
Planar groups (Å) 0.010
van der Waals contacts (Å) 0.016
Rms difference in B for
Neighboring atoms (Å2) 1.98
a For molecule A and B, respectively.
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By plotting log(x/Xmax 2 x) versus log[S] (Hill plot), a straight line is
obtained (secondary plot). In this plot, the slope of the line gives the Hill
constant h, the y intercept is 2hzlog K50 and the x intercept is log K50.
Ki values for the inhibitory effect of b-cyclodextrin on kinetics of the
















In Equation 3, K50i is the apparent K50 when b-cyclodextrin is added,
and Ki1 is the concentration b-cyclodextrin at which the apparent K50 is
2zK50. In Equation 4, Vmaxi is the apparent Vmax when b-cyclodextrin is
added and Ki2 is the concentration of b-cyclodextrin at which the ap-
parent Vmax is 1/20zVmax.
Crystallization and Data Collection—Attempts to crystallize the
W616A mutant CGTase under similar conditions as the wild type (5)
resulted in phase separation in the hanging drops. Therefore, a Sparse
matrix (33) (48 experiments) was set up using hanging drops with a
protein concentration of 8 mg/ml in 10 mM sodium acetate buffer, pH
5.5, at room temperature. Five conditions, all containing PEG8000 at
pH 5.5–7.3, resulted in crystalline material. Refinement of these con-
ditions showed that the biggest crystals could be grown from 9–12%
(w/v) PEG8000 at pH 6.8 to 7.2. Many crystals were intergrown plates
or twinned needles, but a small number of them were rod-shaped single
crystals belonging to the monoclinic spacegroup P21 with cell dimen-
sions a 5 73.7 Å, b 5 84.8 Å, c 5 118.3 Å, and b 5 107.0°. X-ray
diffraction data were collected on a MacScience Dip2000K image plate
system and processed with XDS (34) yielding a data set of 50,563
unique reflections with an Rsym of 8.3% and 71.3% completeness to 2.2
Å resolution.
Molecular Replacement—Molecular replacement was carried out
with the native CGTase structure (without maltoses or solvent and with
residue Trp-616 replaced by Ala) as the search model. The rotation and
translation functions (35, 36) were solved with diffraction data in the
8.0–4.0 Å resolution range. Two unique solutions were obtained at 9s,
indicating the presence of a dimer in the asymmetric unit. The relative
y coordinates of the two solutions were determined with the program
BRUTE (37). The two solutions correspond to a rotation of the search
model over a 5 77.5°, b 5 140.0°, and g 5 150.0° and a translation in
fractional coordinates of 0.13, 0.00, and 0.24 for the first solution and a
rotation of a 5 105.0°, b 5 100.0°, g 5 355.0° and a translation of 0.44,
0.44, and 0.03 for the second solution.
Structure Refinement—Both molecules were subjected to rigid body
refinement with TNT (38), followed by alternating manual adjustments
with O (39) and refinement with TNT. Free R-factors (40) were calcu-
lated using 5% of the data. The final model has crystallographic and
free R-factors of 19.3 and 25.0%, respectively, and good stereochemistry
(see Table I). The final model has been deposited at the protein data-
bank (41) (entry code 1TCM).
RESULTS AND DISCUSSION
Structures of Maltose Binding Sites in the E-domain—In
previous studies, we identified two maltose binding sites (MBS)
FIG. 2. Construction of plasmid
pDP66K. Subcloning steps are indicated
adjacent to the arrows.
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in the E-domain of B. circulans strain 251 CGTase (5). MBS1
includes Trp-616 and Trp-662, which bind a maltose unit
through van der Waals contacts of their indole groups with the
glucose rings. Direct hydrogen bonds with the side groups of
Lys-651 and Asn-667 and water-mediated hydrogen bonds with
the main chain carbonyl oxygen atoms of Trp-616 and Glu-663
further enhance maltose binding (Fig. 1) (5). In MBS2, Tyr-633
forms van der Waals contacts with a glucose residue. Direct
hydrogen bonds with the side chains of Thr-598, Asn-627, and
Gln-628, the main chain carbonyl oxygen atoms of Ala-599 and
Gly-601, and one water-mediated hydrogen bond with Asn-603
complete maltose binding (Fig. 1) (5). MBS2 is located near a
groove leading to the active site (Fig. 3), indicating that its
function may be a combination of starch binding and guiding
the substrate into the groove leading to the active site. A third
MBS, located at the C-domain, has also been identified (5). The
distances between the different MBS sites measured over the
surface of the protein are from MBS1 to MBS2, 30Å; from
MBS1 to MBS3, 60Å; and from MBS2 to MBS3, 52Å (6 5Å).
Recently, we showed that cyclodextrins bind at MBS1 and
MBS2 but not (or less) at MBS3 (Fig. 3) (20). The functions of
MBS1 and MBS2 in the E-domain were studied further by
replacing the residues responsible for hydrophobic interactions
with sugar residues (Trp-616, Tyr-633, and Trp-662) by alanine
residues. The biochemical and structural properties of these
mutant CGTase proteins are reported below.
MBS1 (Trp-616, Trp-662) Is Most Important for the Raw
Starch Binding Capacity—The wild-type protein has a high
affinity toward raw starch, and at high substrate concentra-
tion, virtually all of the enzyme is bound to the raw starch (Fig.
4(A1) and Table II). Especially, the W616A/W662A mutations
in MBS1 clearly affected raw starch binding, resulting in
highly decreased affinities as shown by the strongly enhanced
K50 (dissociation constant) values (Fig. 4(B) and Table II).
TheY633A mutation in MBS2 also resulted in a strong increase
of the K50 value (Fig. 4(C) and Table II). The W616A and
W616A/W662A mutations also resulted in a decreased binding
capacity indicated by the strongly reduced Bmax (maximal frac-
tion of bound protein) values (Fig. 4(B1) and Table II). The
Y633A mutation had much less effect on Bmax values (Fig.
4(C1) and Table II). From this, we conclude that MBS1 (Trp-
616, Trp-662) is of crucial importance for raw starch binding,
while MBS2 (Tyr-633) especially improves the binding affinity
for raw starch and only makes a relatively small contribution to
the binding capacity.
The Hill factor h (the degree of cooperativity) for raw starch
binding is 1.7 for the wild-type CGTase, indicating that at least
two sites are involved in binding (Table II). The Hill factors
have severely decreased in mutants W616A and W616A/
W662A, demonstrating that in wild-type CGTase MBS1 is one
of the sites contributing to cooperative binding. Mutant Y633A
has an intermediate Hill factor; cooperativity in raw starch
binding thus was less affected in this mutant. This suggests
that one or more sites other than MBS2 cooperate with MBS1
in raw starch binding in wild-type CGTase. This is in agree-
ment with the residual starch binding occurring in the W616A/
W662A mutant. Conceivably, these alternative sites are the
FIG. 4. Primary plots (A-, B-, or C1) and Hill plots (A-, B-, or C2)
for binding to raw starch of B. circulans strain 251 wild type (A),
W616A/W662A (B), and Y633A (C) mutant CGTase enzymes in the
presence of 0.1 mM[r (E) and 0 mM (l) b-cyclodextrin.
FIG. 3. Stereo representation of a-cyclodextrin stacked over the hydrophobic residues of the maltose binding sites in the
E-domain of B. circulans strain 251 CGTase. Visible also are maltose stacked on maltose binding site three (MBS3) in the C-domain and
maltotetraose (G4) in the active site (20).
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active site cleft and/or MBS3 in the C-domain. Preliminary
results with an MBS3 mutant indicate that this site is indeed
involved in raw starch binding (not shown).
b-Cyclodextrin Competitively Inhibits Raw Starch Binding at
MBS1—Under cyclodextrin production conditions, B. circulans
strain 251 CGTase suffers from product inhibition (19). A crys-
tallographic analysis of cyclodextrin binding to CGTase re-
vealed that cyclodextrin is bound at MBS1 and MBS2 (20) in
the E-domain (Fig. 3), but not at MBS3 in the C-domain, or in
the active site. We have now observed that the presence of
b-cyclodextrin indeed affected the raw starch binding proper-
ties of the wild-type CGTase (Fig. 4(A) and Table II). Addition
of b-cyclodextrin resulted in an unchanged raw starch binding
capacity (indicated by Bmax) but in an increased K50 (dissocia-
tion constant) value for the wild-type CGTase, reflecting a
decreased affinity for raw starch. b-Cyclodextrin thus compet-
itively inhibits raw starch binding by the wild-type enzyme.
Almost the same competitive effect was observed for mutant
Y633A (Fig. 4(C) and Table II), indicating that with an im-
paired MBS2, the effect of b-cyclodextrin on raw starch binding
had not changed. This again illustrates that MBS2 does not
contribute substantially to raw starch binding. The effect of
b-cyclodextrin on the binding of raw starch by mutants W616A
and W616A/W662A, however, was completely different. Here
the K50 values did not change upon addition of b-cyclodextrin
(Fig. 4(B2) and Table II), while the raw starch binding capacity
(indicated by Bmax) was severely decreased (Fig. 4(B1) and
Table II). b-Cyclodextrin, thus, non-competitively inhibits raw
starch binding by CGTase mutants with an impaired MBS1. It
follows that in the wild-type CGTase, binding competition be-
tween raw starch and b-cyclodextrin takes place at MBS1.
MBS2 (Tyr-633) Is Most Important for Guiding Linear
Starch Chains into the Active Site—The raw starch binding
studies show that MBS1 is important for the binding capacity,
while MBS2 enhances the affinity, suggesting that these sites
have distinct functions. Kinetic studies of the cyclization activ-
ity of (mutant) CGTase proteins with soluble starch (Paselli
SA2) as substrate were performed to further elucidate these
functions (Fig. 5 and Table III). Mutations in MBS1 and MBS2
had relatively minor effects on the Vmax (maximal velocity of
the reaction) values. The mutations W616A/W662A in MBS1
resulted in a doubling of the K50 (dissociation constant) value
(Table III), indicating that binding of the substrate at MBS1 on
the E-domain enhances the affinity of the enzyme for the sub-
strate. Although MBS2 does not strongly contribute to raw
starch binding capacity, mutation Y633A resulted in an even
more increased K50 value (Table III), indicating a strongly
reduced affinity for the substrate. This, together with the fact
that MBS2 is situated at the beginning of the groove leading to
the active site (Fig. 3), suggests a role for MBS2 in guiding the
substrate to the active site. The cooperativity factor h de-
creased to 1 for all mutants, indicating complete loss of coop-
erativity (Table III). This implies that both MBS1 and MBS2
are crucial for the cooperativity observed in cyclization reaction
kinetics on Paselli SA2. In the absence of MBS1, the affinity of
MBS2 for the substrate is very low (Table II), causing a reduced
efficiency of this MBS2; furthermore, MBS2 and the active site
cleft can be regarded as one binding site for a high molecular
substrate. In the absence of MBS2 the substrate will still bind
to MBS1, but it is not efficiently guided to the active site.
b-Cyclodextrin Inhibits the Cyclization Reaction at the Active
Site and by Interfering with MBS2—b-Cyclodextrin reduces
the capacity of CGTase to bind raw starch (Table II). Also, the
cyclization reaction with soluble starch is inhibited by b-cyclo-
dextrin (Table III). This inhibitory effect on the cyclization
reaction was investigated further to see whether it involves the
maltose binding sites. For the wild-type enzyme, the presence
of b-cyclodextrin resulted in clearly decreased Vmax and in-
creased K50 values (Fig. 5(A) and Table III). Inhibition of cycli-
zation activity by b-cyclodextrin, therefore, appears to be of a
mixed type (32). This type of inhibition can be divided into an
effect on the K50 normally observed for competitive inhibition,
yielding Ki1, and an effect on the Vmax normally observed for
non-competitive inhibition, yielding Ki2 (Table III). So in the
wild type, b-cyclodextrin interferes competitively with the cy-
clization reaction at the active site and non-competitively else-
where on the enzyme. The W616A and W616A/W662A mutants
showed the same type of inhibition as the wild type, with Ki
FIG. 5. Primary plots (A-, B-, or C1) and Hill plots (A-, B-, or C2)
for the reaction kinetics on Paselli SA2 (soluble starch) of B.
circulans strain 251 wild type (A), W616A/W662A (B), and Y633A
(C) mutant CGTase enzymes in the presence of 2 mM (), 1 mM
(f), and 0 mM (l) b-cyclodextrin. The seemingly random distribu-
tion of points at high Paselli SA2 concentrations (A2) are caused by the
low K50 and high h values for the wild-type enzyme.
TABLE II
Binding properties of B. circulans strain 251 wild type and mutant CGTase proteins with raw starch (RS): effects of b-cyclodextrin (CD)
(Mutant) protein
Bmax K50 (% RS) h
0 mM b-CD 0.1 mM b-CD 0 mM b-CD 0.1 mM b-CD 0 mM b-CD 0.1 mM b-CD
Wild type 1.00 6 0.02 0.99 6 0.03 0.79 6 0.03 1.06 6 0.07 1.78 6 0.11 1.56 6 0.14
W616A 0.63 6 0.03 0.42 6 0.02 1.56 6 0.21 1.30 6 0.15 1.05 6 0.09 1.41 6 0.18
W616A/W662A 0.49 6 0.01 0.33 6 0.02 2.36 6 0.13 2.27 6 0.30 1.19 6 0.06 1.07 6 0.07
Y633A 0.88 6 0.02 0.81 6 0.02 1.52 6 0.07 1.97 6 0.09 1.30 6 0.06 1.17 6 0.04
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values for b-cyclodextrin, which did not differ significantly
from the wild-type values (Table III). Upon addition of b-cyclo-
dextrin, the Y633A Vmax, however, was less affected, resulting
in a higher Ki2, while its K50 value increased more, resulting in
a lower Ki1 (Fig. 5(C) and Table III). This indicates that in
wild-type CGTase, non-competitive inhibition is mainly caused
by interference of b-cyclodextrin with the function of MBS2. A
b-cyclodextrin bound to this site may not only prevent starch
binding but also block the groove leading to the active site (Fig.
3) (5, 20). The more pronounced competitive type of inhibition
of the cyclization reaction in the Y633A mutant is probably a
direct effect of the decreased non-competitive inhibition; the
relatively higher Vmax, upon addition of b-cyclodextrin com-
pared with the wild-type and other mutant enzymes, automat-
ically results in a higher K50.
The raw starch binding studies showed that MBS1 (Trp-616,
Trp-662) is crucial for raw starch binding, while the kinetic
studies of cyclization activity on Paselli SA2 clarified that
MBS2 (Tyr-633) has a function in guiding linear starch chains
into the active site.
The Functions of MBS1 and MBS2 Are Equally Important
for Cyclization Activity with Raw Starch—The cyclization re-
action kinetics was also studied with raw starch as substrate
(Fig. 6 and Table IV). Mutations W616A (MBS1) and Y633A
(MBS2) resulted in increased K50 (dissociation constant) val-
ues, while Vmax (maximal velocity of the reaction) values re-
mained unaffected (Table IV). The kinetic parameters of the
W616A/W662A mutant could not be measured accurately be-
cause of a shift in the curve (Fig. 6); most likely, its Vmax
approaches those of wild type and the W616A and Y633A
CGTases, and its K50 value approaches those of mutants
W616A and Y633A. The results nevertheless clearly indicate
that the affinity toward raw starch in the cyclization reaction is
much higher when both MBS1 and MBS2 are present (Fig. 6).
The Y633A mutation resulted in a similarly reduced affinity for
raw starch (Table IV) and Paselli SA2 (Table III) when study-
ing the cyclization reaction kinetics. As discussed above, loss of
MBS2 converts CGTase into a protein that is less efficient in
guiding the starch chain to the active site, while loss of MBS1
results in a reduced ability to bind to raw starch granules. For
the conversion of raw starch into cyclodextrins, both these
features of the two maltose binding sites are equally important.
At the surface of starch granules, chains of varying lengths
may protrude into the medium. Binding of CGTase protein to a
starch granule will result in an increased local concentration of
substrate for the enzyme. Loss of binding, therefore, results in
a decrease in the effective substrate concentration, and thus in
an increased K50 value. Fig. 6 shows that, up to a concentration
of 35% raw starch, mutations in both MBS1 and MBS2 appear
to have similar effects. At higher raw starch concentrations,
however, the cyclization activity of the W616A/W662A mutant
(MBS1) shifts toward the level displayed by wild type. This
shift in the curve suggests that MBS1 is functionally replaced
by another binding site. Conceivably, this site is MBS3 in the
C-domain, also involved in raw starch binding. This effect may
only be visible at high raw starch concentrations because of the
relatively long distance between MBS3 and MBS2, which
might cause a high Hill factor value (Fig. 6(B), (hypothetical)
dotted line). Starch chains of sufficient length may be scarce on
the surface of the starch granule, resulting in a high K50 value
(Fig. 6(A), (hypothetical) dotted curve).
Crystal Structure of the W616A Mutant CGTase—In wild-
type CGTase, the maltose that is bound to MBS1 is involved in
crystal packing contacts (5). Replacement of Trp-616 by Ala
reduced the affinity for binding of carbohydrate chains at this
site. This has resulted in a novel maltose-independent crystal
FIG. 6. Primary plots (A) and Hill plots (B) for the reaction
kinetics on raw starch of B. circulans strain 251 wild type (l),
W616A/W662A (M), and Y633A (f) mutant CGTase enzymes. The
dotted line indicates the modeled curve resulting from the supposed
interaction between MBS2 (E-domain) and MBS3 (C-domain).
TABLE III
Kinetic properties of the cyclization reaction of B. circulans strain 251 wild type and mutant CGTase proteins with Paselli SA2;
effects of b-cyclodextrin (CD)
(Mutant) protein Vmax K50 h Ki1
a Ki2
b
units/mg mM mM mM
Wild type 271.2 6 1.7 0.028 6 0.003 2.3 6 0.6 1.35 6 0.59 8.1 6 1.0
W616A 251.0 6 3.2 0.037 6 0.005 c 0.84 6 0.31 11.5 6 1.8
W616A/W662A 248.8 6 3.7 0.062 6 0.006 c 1.95 6 0.51 10.4 6 1.6
Y633A 319.0 6 5.7 0.092 6 0.010 c 0.58 6 0.07 27.8 6 9.7
a Ki1 represents competitive inhibition.
b Ki2 represents non-competitive inhibition.
c Fitting of these data was performed using the Michaelis-Menten equation (h 5 1).
TABLE IV
Kinetic properties of the cyclization reaction of B. circulans strain
251 wild type and mutant CGTase proteins with raw starch
(Mutant) protein Vmax K50
units/mg % RS
Wild type 15.3 6 0.5 18.4 6 1.3
W616A 14.4 6 2.1 43.3 6 11.4
W616A/W662A (15.3) (42.5)
Y633A 16.0 6 0.5 42.5 6 2.7
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form. The W616A mutant CGTase crystallizes as a dimer with
the mutated MBS1 of each monomer face to face (Fig. 7).
Dynamic light scattering measurements of the protein dis-
solved in 10 mg/ml a-cyclodextrin and 10 mM sodium acetate,
pH 5.5, showed, however, that the protein is monomeric in
solution (results not shown) and that, therefore, the dimeric
form is a crystallographic artifact. The two protein molecules in
the dimer, called A and B, respectively, are related to each
other by a rotation of 170° resulting in different local environ-
ments of the two molecules. The largest changes in the protein
backbone conformation occur at residues A336–A338, A665–
A659, B40–B43, B89–B91, B598–B603, and B655–B659, all of
which are located at the surface of the protein, near the dimer
interface or crystal packing contacts. The dimer interface is
mainly polar, with the exception of a stacking interaction be-
tween the indole groups of Trp A662 and Trp B662. A summary
of direct hydrogen bonds and hydrophobic interactions at crys-
tal contacts and within the dimer interface is presented in
Table V. Electron density in sa-weighted 2uFo 2 Fcu maps (42) at
position 616 in both monomers (Fig. 8) confirms that the Trp-
616 to Ala mutation has been successful. In conclusion, the
crystal structure of the W616A mutant CGTase shows that the
mutation at MBS1 does not induce large structural changes in
the overall fold of the protein but merely influences crystal
packing due to the altered sugar binding capacity of the en-
zyme. The modified starch binding and cyclization kinetic prop-
erties observed with the mutant CGTase proteins thus are not
due to conformational changes but can be directly related to the
amino acid replacements.
CONCLUSIONS
Our data suggest the following functions for the maltose
binding sites in the B. circulans strain 251 CGTase E-domain.
MBS1 (with Trp-616, Trp-662) is required for efficient binding
to raw starch granules with a minor contribution from MBS2
(with Tyr-633) and a major contribution from an additional
binding site, probably MBS3 (with Trp-413, in the C-domain).
A b-cyclodextrin bound at MBS1 competitively inhibits binding
of CGTase to raw starch granules. The cyclization reaction
kinetics with soluble starch indicated that MBS2 has an im-
portant role in guiding linear starch chains to the active site.
For wild-type CGTase, a mixed type of inhibition by b-cyclo-
dextrin was observed. Competitive inhibition takes place at the
active site, while non-competitive inhibition results from inter-
ference of b-cyclodextrin with substrate binding at MBS2.
b-Cyclodextrin bound at MBS2 may block the groove leading to
FIG. 7. Stereo view of the Ca-trace
of the crystallographic dimer of the
W616A mutant of CGTase from B. cir-
culans strain 251. The W616A mutant
is drawn with thick lines while the super-
imposed wild-type enzyme structure is
drawn in thin lines. The maltose binding
sites and the corresponding aromatic res-
idues have been indicated. The W616A
structure deviates only from the wild-type
at regions near crystal contacts and the
dimer interface.
TABLE V
Inter-molecular hydrogen bonds and van der Waals interactions of the W616A CGTase mutant
For van der Waals interactions, only the shortest distance between two residues is listed. Symmetry operation 1 denotes contacts within the
dimer.
van der Waals interactions Distance Hydrogen bonds Distance
Atom 1 Atom 2 (Å) Symopa Atom 1 Atom 2 (Å) Symopa
Trp A662-Ch2 Trp B662-Cd1 3.0 1 Ala A616-O Trp B662-Ne1 3.0 1
Phe A39-Ce2 Tyr A301-Ce2 3.6 2 Asp A617-Od1 Asp B617-Od1 3.0 1
Gly A41-Ca Tyr A301-Ce2 3.5 2 Trp A662-N Gly B665-O 2.7 1
Asp B147-Cb Val B265-Cg2 3.5 3 Trp A662-O Gly B665-N 3.3 1
Asp A147-O Tyr A492-OH 3.0 4
Ser A205-Og Gln B453-O 3.4 4
Thr A206-Og1 Gln B453-Ne2 2.8 4
Asn A336-Od1 Ser A658-Og 2.9 2
Ala A557-N Ser B90-Og 3.3 5
Asn A681-O Cys B400-Sg 2.8 4
Pro A686-O Lys B128-Nz 3.3 4
Tyr B301-OH Gln B632-Oe1 3.1 5
Asn B416-Od1 Gln B632-Ne2 3.3 5
Asn B416-Nd2 Gln B632-Oe1 2.8 5
a Symop, Symmetry operations are 1 5 X, Y, Z; 2 5 1 2 X, Y 1 0.5, 1 2 Z; 3 5 1 6 X, Y 2 0.5, 2Z; 4 5 X 2 1, Y, Z; 5 5 1 2 X, Y 1 0.5, 2Z.
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the active site. The cyclization reaction kinetics with raw
starch revealed that these different roles of MBS1 and MBS2
are equally important for degradation of raw starch.
Structural analysis of the W616A mutant CGTase revealed
only minor changes compared with the wild-type enzyme. The
modified starch binding and cyclization kinetic properties ob-
served with the mutant CGTase proteins thus can be directly
related to the amino acid replacements.
The data obtained on the functions of the CGTase E-domain
in raw starch binding have important implications for our
understanding of this process in glucoamylase and other mem-
bers of the a-amylase family (9–12, 16, 43–45).
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FIG. 8. Electron density in 2zFo 2 Fcz
maps contoured at 1s for residues
A614–A618 and B614–B618, labeled A
and B, respectively. Residues adjacent
to the mutated tryptophan have been in-
dicated. The replacement of Trp-616 by
Ala is confirmed by the electron density in
this region.
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